Browse Studies — Arctuva

Phase 1

Buprenorphine for the Management of Pain in Children With Sickle Cell Disease

The goal of this clinical trial is to learn whether a single dose of buccal buprenorphine (BELBUCA) is safe when used in place and/or with full agonist opioids…

Sickle Cell Disease (SCD)Sickle Cell Disease Vaso-occlusive CrisisSickle Cell Anemia Crisis+4 more

Estimated

~$10 – $7,500

Natasha ArcherNCT07799571

Observational

A Multi-Center, Randomized, Controlled, Cross-Over Study to Evaluate the Effectiveness of Hypoxic Red Blood Cells Processed With the Hemanext ONE® System Versus Conventional Red Blood Cells in Patients With Transfusion Dependent Sickle Cell Anemia

The overall objective of this study is to evaluate the effectiveness and safety of transfusing hypoxic red blood cells manufactured with the Hemanext ONE syste…

Sickle Cell AnaemiaSickle Cell Anemia CrisisSickle Cell Anemia in Children+1 more

Estimated

~$10 – $7,500

HemanextNCT06743113

Observational

Development of a Provider-Focused Intervention to Improve Health Outcomes in Pediatric Sickle Cell Disease

The goal of this interventional study is to learn about the impact of an intervention for health care providers that teaches individuation and perspective-taki…

Sickle Cell DiseaseSickle Cell Anemia in ChildrenSickle Cell Disease (SCD)+2 more

Estimated

~$10 – $6,250

Connecticut Children's Medical CenterNCT07540767